NCT00201630View on ClinicalTrials.gov

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy

PHASE3UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

Uroxatrol (drug)

Trial Locations (1)

11572

New York Prostate Institute, Oceanside

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

New York Prostate Institute

OTHER